Italiano
- CNCCS Scarl
- IRBM S.p.A.
The CNCCS Consortium, in partnership with IRBM S.p.A., launched the POINTEC project—an 18-month investment program aimed at strengthening the CNCCS infrastructure, with a dual focus on the management of the collection of synthesized organic chemical compounds and its use in screening activities and drug discovery. The partnership aims to enhance both the technological infrastructure and the scientific network within the PNIR framework, steering CNCCS toward new research and technology transfer goals, while leveraging the experience gained through previous national and international collaborations.
Specifically, POINTEC is intended both to maintain the infrastructure’s status as a center of excellence—by modernizing a significant portion of its instrumentation—and to broaden collaborations across the European landscape. The project aims to evolve the research infrastructure into a European Central Facility and to establish connections with similar institutions in Europe. Participating institutions and research centers will be able to enrich the compound collection with their own submissions and benefit from access to the full sample collection for research and development purposes within their own projects.
Starting from the existing infrastructure, the proposed enhancement will focus on high-throughput technologies, structured around four main and interconnected pillars:
- Modernization of the compound management platform.
- Strengthening of the screening instrumentation platform.
- Technological advancement of the Phage Display platform.
- Technological advancements to accelerate the identification and characterization of new potential therapeutic agents (small molecules, antibodies, and peptides).
